Nifty 50 ended the week down 0.3% at 24,206.9 — still below its 200-day average and 8.1% off its 52-week high. The week's defining moment was Wednesday's 2.1% drop, which pushed the short-term breadth gauge to 34.9% and briefly flipped net new highs negative; Thursday and Friday clawed most of that back, but the recovery is a bounce off a bruise, not a clean reset. The share of stocks above their 200-day average actually narrowed slightly, from 44% to 43.3%, across the five sessions — the structural gauge barely moved, which tells you the week's volatility was noise inside a slow, grinding recovery rather than a decisive turn either way.
A week shaped by one bad day
Monday and Tuesday looked orderly enough — Nifty added 0.4% and 0.7% respectively, and the short-term breadth gauge was still above 59%. Then Wednesday delivered a 2.1% index drop with decliners outnumbering advancers nearly 5-to-1 and net new highs turning negative for the first time in the series. That single session did most of the week's damage. Thursday's 0.3% bounce and Friday's 1% recovery brought advancers back to 1,599 against 613 decliners and pushed net new highs to 141, but the short-term breadth gauge closed the week at 50.2% — below where it started on Monday. The trajectory for the week is range-bound and mixed: no decisive breadth trend, no clean leadership, and an index that is still on the wrong side of its 200-day average.
Stage-2 cohort: slow expansion, not a surge
The advancing cohort grew by 8 names over the week to 794 stocks, or 35.5% of the market. Forty-seven stocks moved from Stage 1 into Stage 2 against 30 moving from Stage 2 into Stage 3 — a net addition of 17, which is constructive but modest. The 20-day expansion figure of +9.8 and the 60-day figure of +27 confirm the cohort has been widening for some time; the week's +8 is consistent with that pace, not an acceleration. Health Care, Consumer Discretionary and Financials are where the Stage-2 cohort is expanding fastest on a 20-day basis, and that is reflected in the week's new transitions: Ramco Systems and Unichem Laboratories cleared the Stage 1-to-2 threshold with the highest setup scores among the week's entrants, joined by names from Consumer Discretionary — Orbit Exports, Oriental Hotels and V-mart Retail — and Religare Enterprises from Financials.
What the internals say about the weeks ahead
The bull-rising regime has now held for 28 consecutive days, and the near-term read is neutral-to-up — but those labels describe the regime, not the momentum. The structural breadth gauge at 43.3% means fewer than half of NSE-listed stocks are above their 200-day average; 196 stocks closed the week at 52-week highs against 55 at new lows, a net of +141 that is healthy in isolation but was briefly negative mid-week. The honest read is that the market is recovering slowly from a deeper correction, the Stage-2 cohort is widening at a measured pace, and one bad session can still wipe out several days of progress in the short-term gauges. Real Estate and Health Care are the sectors with the most durable structural strength; IT's one good week does not override three months of underperformance. Until the 200-day average breadth gauge pushes meaningfully above 50% and the index reclaims its own 200-day average, this remains a stock-picker's tape inside a fragile recovery — not a broad advance.
| Stock | Sector | Move | Setup |
|---|---|---|---|
| Ramco Systems Ltd | Information Technology | 1→2 | 9.4 |
| Unichem Laboratories Ltd | Health Care | 1→2 | 9.0 |
| Orbit Exports Ltd | Consumer Discretionary | 1→2 | 8.4 |
| Oriental Hotels Ltd | Consumer Discretionary | 1→2 | 8.4 |
| Tarsons Products Ltd | Health Care | 1→2 | 7.8 |
| Religare Enterprises Ltd | Financials | 1→2 | 7.3 |
| Thejo Engineering Ltd | Industrials | 1→2 | 6.8 |
| V-mart Retail Ltd | Consumer Discretionary | 1→2 | 6.8 |
| Stock | Sector | Setup | RS |
|---|---|---|---|
| S.P.Apparels Ltd | Consumer Discretionary | 9.4 | 87 |
| Lokesh Machines Ltd | Industrials | 9.4 | 95 |
| Aurum Proptech Ltd | Information Technology | 9.4 | 76 |
| Fusion Finance Ltd | Financials | 9.4 | 78 |
| Tirupati Forge Ltd | Consumer Discretionary | 9.4 | 91 |
| IND Swift Laboratories Ltd | Health Care | 9.2 | 97 |
| Macpower CNC Machines Ltd | Industrials | 9.0 | 88 |
| Beta Drugs Ltd | Health Care | 9.0 | 87 |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Real Estate | +3.1% | +22.1% | +25.2% | 54 | 22% |
| Information Technology | +1.8% | +0.9% | -2.3% | 35 | 28% |
| Energy | +1.7% | +4.2% | -1.0% | 54 | 39% |
| Financials | +1.6% | +7.9% | +3.3% | 61 | 35% |
| Utilities | +1.6% | +1.2% | +17.7% | 63 | 30% |
| Materials | +1.4% | +2.0% | +7.4% | 67 | 38% |
| Industrials | +1.3% | +5.2% | +20.0% | 68 | 39% |
| Consumer Discretionary | +0.8% | +7.4% | +8.4% | 66 | 35% |
| Health Care | +0.4% | +7.1% | +20.7% | 73 | 50% |
| Consumer Staples | +0.1% | +1.8% | +6.8% | 56 | 33% |
| Communication Services | +0.1% | +9.3% | +14.2% | 61 | 18% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty +0.5% but decliners won — breadth eroding
The index held; the internals didn't. Two straight sessions of decliners beating advancers says this is not a dip inside strength.
Nifty flat, internals slipping — not a dip to buy
Decliners led 1,374 to 1,117; the Stage-2 cohort shed 2.8 points in five days. The tape is hollowing out.
Nifty flat, internals mixed — range-bound holds
Decliners edged advancers today. The tape is recovering but not yet convincing. Here's where things stand.